08037.HK
China Biotech Services Holdings Limited
HKSE · Healthcare · Medical - Diagnostics & Research · HK
HKD 0.63
+3.28%Leverage
- Debt / equity
- 2.13x
- Net debt / equity
- 1.89x
- Debt / assets
- 0.57x
- Debt / EBITDA
- -7.60x
- Net debt / EBITDA
- -6.71x
Liquidity & coverage
- Current ratio
- 0.99x
- Quick ratio
- 0.63x
- Cash ratio
- 0.34x
- Interest coverage
- -2.50x
- EBITDA / interest
- -1.51x
- Working capital
- -HKD 1.9M
Cash & dividend
- FCF / debt
- -0.43x
- Cash flow / debt
- -0.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -97.5%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026